Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Biomarkers (2)
- Proteomics (2)
- Statistical Models (2)
- 2D Gel Electrophoresis (1)
- Bayesian Modeling (1)
-
- Bayesian methods (1)
- Classification (1)
- Copy number (1)
- False Discovery Rate (1)
- Functional Data Analysis (1)
- Functional Mixed Models (1)
- Genomics (1)
- Image Analysis (1)
- Image Data Analysis (1)
- Integrative analysis (1)
- Longitudinal Data Analysis and Time Series (1)
- MALDI-TOF (1)
- Mass Spectrometry (1)
- Multiple Testing (1)
- Nonparametric Regression (1)
- Personalized therapy (1)
- Reproducibility (1)
- Robust Regression (1)
- Sequential randomized controlled trials; targeted maximum likelihood estimation; semi-parametric estimation; efficient estimation; dynamic treatment regimes; longitudinal methods (1)
- Statistical Methodology (1)
- Statistical Theory and Methods (1)
- Wavelets (1)
- Publication
Articles 1 - 4 of 4
Full-Text Articles in Statistical Methodology
Targeted Maximum Likelihood Estimation For Dynamic Treatment Regimes In Sequential Randomized Controlled Trials, Paul Chaffee, Mark J. Van Der Laan
Targeted Maximum Likelihood Estimation For Dynamic Treatment Regimes In Sequential Randomized Controlled Trials, Paul Chaffee, Mark J. Van Der Laan
Paul H. Chaffee
Sequential Randomized Controlled Trials (SRCTs) are rapidly becoming essential tools in the search for optimized treatment regimes in ongoing treatment settings. Analyzing data for multiple time-point treatments with a view toward optimal treatment regimes is of interest in many types of afflictions: HIV infection, Attention Deficit Hyperactivity Disorder in children, leukemia, prostate cancer, renal failure, and many others. Methods for analyzing data from SRCTs exist but they are either inefficient or suffer from the drawbacks of estimating equation methodology. We describe an estimation procedure, targeted maximum likelihood estimation (TMLE), which has been fully developed and implemented in point treatment settings, …
Statistical Methods For Proteomic Biomarker Discovery Based On Feature Extraction Or Functional Modeling Approaches, Jeffrey S. Morris
Statistical Methods For Proteomic Biomarker Discovery Based On Feature Extraction Or Functional Modeling Approaches, Jeffrey S. Morris
Jeffrey S. Morris
In recent years, developments in molecular biotechnology have led to the increased promise of detecting and validating biomarkers, or molecular markers that relate to various biological or medical outcomes. Proteomics, the direct study of proteins in biological samples, plays an important role in the biomarker discovery process. These technologies produce complex, high dimensional functional and image data that present many analytical challenges that must be addressed properly for effective comparative proteomics studies that can yield potential biomarkers. Specific challenges include experimental design, preprocessing, feature extraction, and statistical analysis accounting for the inherent multiple testing issues. This paper reviews various computational …
Integrative Bayesian Analysis Of High-Dimensional Multi-Platform Genomics Data, Wenting Wang, Veerabhadran Baladandayuthapani, Jeffrey S. Morris, Bradley M. Broom, Ganiraju C. Manyam, Kim-Anh Do
Integrative Bayesian Analysis Of High-Dimensional Multi-Platform Genomics Data, Wenting Wang, Veerabhadran Baladandayuthapani, Jeffrey S. Morris, Bradley M. Broom, Ganiraju C. Manyam, Kim-Anh Do
Jeffrey S. Morris
Motivation: Analyzing data from multi-platform genomics experiments combined with patients’ clinical outcomes helps us understand the complex biological processes that characterize a disease, as well as how these processes relate to the development of the disease. Current integration approaches that treat the data are limited in that they do not consider the fundamental biological relationships that exist among the data from platforms.
Statistical Model: We propose an integrative Bayesian analysis of genomics data (iBAG) framework for identifying important genes/biomarkers that are associated with clinical outcome. This framework uses a hierarchical modeling technique to combine the data obtained from multiple platforms …
Proportional Mean Residual Life Model For Right-Censored Length-Biased Data, Gary Kwun Chuen Chan, Ying Qing Chen, Chongzhi Di
Proportional Mean Residual Life Model For Right-Censored Length-Biased Data, Gary Kwun Chuen Chan, Ying Qing Chen, Chongzhi Di
Chongzhi Di
To study disease association with risk factors in epidemiologic studies, cross-sectional sampling is often more focused and less costly for recruiting study subjects who have already experienced initiating events. For time-to-event outcome, however, such a sampling strategy may be length-biased. Coupled with censoring, analysis of length-biased data can be quite challenging, due to the so-called “induced informative censoring” in which the survival time and censoring time are correlated through a common backward recurrence time. We propose to use the proportional mean residual life model of Oakes and Dasu (1990) for analysis of censored length-biased survival data. Several nonstandard data structures, …